“Risk of hepatitis B reactivation in rheumatic patients receiving tocilizumab treatment” (2025) Annals of Medical Research, 32(11), pp. 512–517. Available at: http://www.annalsmedres.org/index.php/aomr/article/view/4880 (Accessed: 2 December 2025).